- Report
- October 2023
- 189 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- October 2023
- 189 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- October 2023
- 181 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- October 2023
- 178 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- October 2023
- 190 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- October 2023
- 190 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- October 2023
- 178 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- October 2023
- 180 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- October 2023
- 181 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- August 2023
- 117 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- June 2023
- 112 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- June 2023
- 115 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- December 2022
- 116 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- December 2022
- 116 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- September 2022
- 115 Pages
Global
From €5185EUR$5,250USD£4,314GBP
€7407EUR$7,500USD£6,163GBP
- Report
- September 2022
- 62 Pages
Global
From €2731EUR$2,765USD£2,272GBP
€3901EUR$3,950USD£3,246GBP
- Report
- September 2022
- 283 Pages
Global
From €5185EUR$5,250USD£4,314GBP
€7407EUR$7,500USD£6,163GBP
- Report
- January 2022
- 60 Pages
Global
From €2731EUR$2,765USD£2,272GBP
€3901EUR$3,950USD£3,246GBP
- Report
- January 2022
- 60 Pages
Global
From €2731EUR$2,765USD£2,272GBP
€3901EUR$3,950USD£3,246GBP
- Report
- November 2023
- 165 Pages
Global
From €2469EUR$2,500USD£2,054GBP
The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more